Moderna | Lånekapital



Loan Capital Endring Dato
Acadia Pharmaceuticals USD 0 0 2024-12
Adcock Ingram Holdings ZAR 220.08M 18M 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 56.55B 305M 2024-12
Arrowhead Research USD 407.79M 14.61M 2024-12
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Celltrion KRW 79.58B 21.94B 2024-09
Cspc Pharmaceutical CNY 56.14M 10.18M 2024-12
Dianthus Therapeutics USD 0 0 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
Incyte USD 32.64M 899K 2025-03
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
Kangmei Pharma CNY 169.19M 7.26M 2024-09
Knight Therapeutics CAD 36.51M 2.04M 2024-09
Laboratorios Farma EUR 80.5M 17.64M 2024-12
Malin Corporation EUR 0 0 2024-06
Moderna USD 39M 586M 2024-12
Organigram Holdings CAD 43.29M 12.19M 2024-12
Pharma Mar EUR 40.24M 992K 2025-03
Qiagen NV USD 1.34B 26.51M 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
Sartorius EUR 4.2B 178.6M 2025-03
Sino Biopharmaceutical CNY 2.08B 915.47M 2024-12
Tilray USD 316.63M 15.02M 2024-11
Ultragenyx Pharmaceutical USD 0 0 2024-12
United Therapeutics USD 0 0 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zz Pientze Pharmaceu 204.54M 8.18M 2025-03



Moderna Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.